• Philip Morris International (PM) fell 5.5% to $163.73 in after-hours trading on June 22, driven by several significant factors.
  • The decline is attributed to intensifying global regulatory restrictions, including generational tobacco bans and restrictions on nicotine pouches.
  • Investors are also reacting to an impending $500 million non-cash impairment charge related to its Canadian affiliate, RBH, for Q2 2026, which led to a revised full-year EPS guidance reduction.
  • Further pressure comes from pricing strategies for new products like ZYN Ultra and surging illicit trade in Europe.